Pharmacological inhibition of STING reduces neuroinflammation‐mediated damage post‐traumatic brain injury
British Journal of Pharmacology · 2024-09 · 181 (17) · 3118-3135
DOI: 10.1111/bph.16347 ↗At a glance
Journal article in British Journal of Pharmacology, published online on 2024-05-06. Written by Amelia L Fryer and 9 co-authors. Institution: Neuropharmacology Laboratory, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia. Major MEDLINE topics: Brain Injuries, Traumatic, Membrane Proteins, Neuroinflammatory Diseases, Mice, Inbred C57BL. Cited 29 times so far (Crossref); 69 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Health and Medical Research Council (NHMRC), The Brain Foundation, BRAINnet Foundation.
Abstract (original language)
Background and Purpose Traumatic brain injury (TBI) remains a major public health concern worldwide with unmet effective treatment. Stimulator of interferon genes (STING) and its downstream type‐I interferon (IFN) signalling are now appreciated to be involved in TBI pathogenesis. Compelling evidence have shown that STING and type‐I IFNs are key in mediating the detrimental neuroinflammatory response after TBI. Therefore, pharmacological inhibition of STING presents a viable therapeutic opportunity in combating the detrimental neuroinflammatory response after TBI. Experimental Approach This study investigated the neuroprotective effects of the small‐molecule STING inhibitor n‐(4‐iodophenyl)‐5‐nitrofuran‐2‐carboxamide (C‐176) in the controlled cortical impact mouse model of TBI in 10‐ to 12‐week‐old male mice. Thirty minutes post‐controlled cortical impact surgery, a single 750‐nmol dose of C‐176 or saline (vehicle) was administered intravenously. Analysis was conducted 2 h and 24 h post‐TBI. Key Results Mice administered C‐176 had significantly smaller cortical lesion area when compared to vehicle‐treated mice 24 h post‐TBI. Quantitative temporal gait analysis conducted using DigiGait™ showed C‐176 administration attenuated TBI‐induced impairments in gait symmetry, stride frequency and forelimb stance width. C‐176‐treated mice displayed a significant reduction in striatal gene expression of pro‐inflammatory cytokines Tnf‐α , Il‐1β and Cxcl10 compared to their vehicle‐treated counterparts 2 h post‐TBI. Conclusion and Implications This study demonstrates the neuroprotective activity of C‐176 in ameliorating acute neuroinflammation and preventing white matter neurodegeneration post‐TBI. This study highlights the therapeutic potential of small‐molecule inhibitors targeting STING for the treatment of trauma‐induced inflammation and neuroprotective potential.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Neuropharmacology Laboratory, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia.
- Department of Biological Sciences, School of Medical and Life Sciences, Sunway University, Subang Jaya, Malaysia.
- Department of Anatomy and Physiology, University of Melbourne, Parkville, Australia.
- Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
- Department of Medical Biology, University of Melbourne, Parkville, Australia.
- Monash Biomedical Imaging, Monash University, Clayton, Australia.
ORCID profiles: Amelia L Fryer, Amar Abdullah, Frank Mobilio, Andrew Jobling, Zachery Moore, Michael de Veer, Gang Zheng, Bruce X Wong, Juliet M Taylor, Peter J Crack
Funding
- National Health and Medical Research Council (NHMRC)
- The Brain Foundation
- BRAINnet Foundation
Cite
APA
Fryer, A. L., Abdullah, A., Mobilio, F., Jobling, A., Moore, Z., de Veer, M., Zheng, G., Wong, B. X., Taylor, J. M., & Crack, P. J. (2024). Pharmacological inhibition of STING reduces neuroinflammation‐mediated damage post‐traumatic brain injury. British Journal of Pharmacology, 181(17), 3118-3135. https://doi.org/10.1111/bph.16347
Vancouver
Fryer AL, Abdullah A, Mobilio F, Jobling A, Moore Z, de Veer M, et al. Pharmacological inhibition of STING reduces neuroinflammation‐mediated damage post‐traumatic brain injury. British Journal of Pharmacology. 2024;181(17):3118-3135. doi:10.1111/bph.16347
BibTeX
@article{Fryer2024,
author = {Fryer, Amelia L and Abdullah, Amar and Mobilio, Frank and Jobling, Andrew and Moore, Zachery and de Veer, Michael and Zheng, Gang and Wong, Bruce X and Taylor, Juliet M and Crack, Peter J},
title = {Pharmacological inhibition of STING reduces neuroinflammation‐mediated damage post‐traumatic brain injury},
journal = {British Journal of Pharmacology},
year = {2024},
volume = {181},
number = {17},
pages = {3118--3135},
doi = {10.1111/bph.16347}
}
EUVIMED